Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 7.34 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 10.5 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 12.4 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 8.88 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 5.77 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 9.93 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 11.5 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 8.98 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 0.0 | BCD100322A01 | 16.6 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 0.5 | BCD100322A03 | 9.34 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 1.0 | BCD100322A07 | 20.5 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 2.0 | BCD100322A11 | 11.3 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 4.0 | BCD100322A15 | 22.6 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 8.0 | BCD100322A19 | 30.9 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 12.0 | BCD100322A23 | 22.1 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | C | 24.0 | BCD100322A27 | 27.5 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 10.6 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 12 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 7.12 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 7.46 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 10 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 10.2 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 12.5 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 0.5 | BCD100322A04 | 23.7 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 1.0 | BCD100322A08 | 19.9 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 2.0 | BCD100322A12 | 20.5 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 4.0 | BCD100322A16 | 22.9 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 8.0 | BCD100322A20 | 21.6 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 12.0 | BCD100322A24 | 18.6 | pmol/sample |
| LMST01010135 | 6α-hydroxy-cholestanol | 25OH-Chol | 24.0 | BCD100322A28 | 24.6 | pmol/sample |